Humboldt University of Berlin spinout Newsenselab has lured High-Tech Gründerfonds and Think.Health Ventures back to the table after an earlier six-figure round in November 2016.

Newsenselab, a Germany-based migraine treatment app spinout from Humboldt University of Berlin, today raised a seven-figure sum in a follow-on round backed by public-private partnership High-Tech Gründerfonds (HTGF) and Think.Health Ventures.
Following the round, Think.Health Ventures has become Newsenselab’s principal investor.
Spun out in 2016 from Humboldt’s department of physics, Newsenselab has developed a digital health app called M-sense that helps tackle migraine and headache outbreaks by using big data analytics to evaluate potential triggers.
M-Sense classifies…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?